Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Harvard Business School
McKinsey
Medtronic
Moodys

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Latrepirdine

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Latrepirdine: Sponsors, patents, clinical trial progress

Latrepirdine is an investigational drug.

There have been 8 clinical trials for Latrepirdine. The most recent clinical trial was a Phase 1 trial, which was initiated on September 1st 2009.

The most common disease conditions in clinical trials are Alzheimer Disease, Huntington Disease, and [disabled in preview]. The leading clinical trial sponsors are Medivation, Inc., Pfizer, and [disabled in preview].

Recent Clinical Trials for Latrepirdine
TitleSponsorPhase
An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's DiseaseMedivation, Inc.Phase 3
An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's DiseasePfizerPhase 3
An Extension of the CONCERT Protocol (DIM18)PfizerPhase 3

See all Latrepirdine clinical trials

Clinical Trial Summary for Latrepirdine

Top disease conditions for Latrepirdine
Top clinical trial sponsors for Latrepirdine

See all Latrepirdine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Mallinckrodt
Moodys
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.